Shlomo Yanai Insider Trading $QPAC Exela Technologies, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Shlomo Yanai.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Shlomo Yanai. Shlomo Yanai is Director in CAMBREX CORP ($CBM) and Director in PDL BIOPHARMA, INC. ($PDLI) and Director in W R GRACE & CO ($GRA) and in Sagent Pharmaceuticals, Inc. ($SGNT) and Director in Sagent Pharmaceuticals, Inc. ($SGNT) and Director in Philip Morris International Inc. ($PM) and Director in PERRIGO Co plc ($PRGO) and Director in Exela Technologies, Inc. ($QPAC) and Director in Amneal Pharmaceuticals, Inc. ($AMRX).

Shlomo Yanai in Exela Technologies, Inc.

Trading Symbol: QPAC
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of Shlomo Yanai: Director
Holdings: 20,500 shares
Current Value: $206,025
Latest Transaction: Jul 14 2017
$QPAC Market Capitalization: $104.93M
$QPAC Previous Close: $10.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Shlomo Yanai in Exela Technologies, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMRX, CBM, QPAC, PDLI, PRGO, PM, SGNT, GRA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 14 2017QPACExela Technologies ...Yanai ShlomoDirectorSellD0.0029,500020,50050 K to 20.5 K (-59.00 %)

Page:   1